Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Indiana
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Indiana
| Provider | Medicare | Services |
|---|---|---|
| Daugherty, Michael M.D. | $111.46 | 49 |
| Nicholson, Mary M.D. | $107.97 | 37 |
| Lackey, Charles D.O. | $118.79 | 36 |
| Wigand, Amy M.D. | $107.37 | 33 |
| Rincker, Rachael MD | $107.88 | 28 |
| Myers, Dennis M.D. | $112.90 | 27 |
| Bommisetty, Lokender MD | $119.43 | 26 |
Indiana Pricing in Context
In Indiana, CPT code 19081 (Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth) carries an average Medicare payment of $150.67 — 28% below the national benchmark of $210.47. 186 providers across the state submitted claims for this procedure in 2023, performing 1.4K total services. Individual payments in IN ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Indiana is $1,168.56, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Indiana sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Indiana lands near $412.63, with self-pay cash prices typically around $468.72. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost in Indiana?
The average Medicare payment for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Indiana is $150.67, which is 28% below the national average of $210.47. Providers in IN typically bill $1,168.56 for this procedure.
What does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost with insurance in Indiana?
With commercial insurance in Indiana, Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs an estimated $412.63. Without insurance, the estimated cash price is $468.72. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Indiana?
186 providers in Indiana billed Medicare for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in 2023, performing 1.4K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cheaper in Indiana than the national average?
Yes — Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs 28% below the national average in Indiana. The state average Medicare payment is $150.67 compared to $210.47 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.